Animal Models of Tuberculosis: An Overview

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Microbiology spectrum

• Publication date

  2016-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/microbiolspec.tbtb2-0004-2015PMID 27726810
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis

  2015cited by this paper
• The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis

  2015cited by this paper
• Immunology studies in non‐human primate models of tuberculosis

  2015cited by this paper
• Response.

  2014cited by this paper
• Critical role for CX3CR1+ mononuclear phagocytes in intestinal homeostasis

  2014cited by this paper
• Memory T cell subsets in tuberculosis: what should we be targeting?

  2014cited by this paper
• The formation of the granuloma in tuberculosis infection.

  2014cited by this paper
• A new unifying theory of the pathogenesis of tuberculosis.

  2014cited by this paper
• Letter to the editor.

  2014cited by this paper
• Modeling tuberculosis in nonhuman primates.

  2014cited by this paper
• MAIT cells and pathogen defense

  2014cited by this paper
• A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data

  2014cited by this paper
• Monkey Models of Tuberculosis: Lessons Learned

  2014cited by this paper
• Tuberculosis Vaccine Types and Timings

  2014cited by this paper
• Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

  2013cited by this paper
• Faculty Opinions recommendation of Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.

  2013cited by this paper
• Characterization of W-Beijing isolates of Mycobacterium tuberculosis from the Western Cape.

  2013cited by this paper
• The zebrafish guide to tuberculosis immunity and treatment.

  2013cited by this paper
• Vaccine Development for Tuberculosis: Current Progress

  2013cited by this paper
• Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafish

  2013cited by this paper
• BCG: myths, realities, and the need for alternative vaccine strategies.

  2012cited by this paper
• Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages.

  2012cited by this paper
• Evaluation of a Mouse Model of Necrotic Granuloma Formation Using C3HeB/FeJ Mice for Testing of Drugs against Mycobacterium tuberculosis

  2012cited by this paper
• Local immune responses in human tuberculosis: learning from the site of infection.

  2012cited by this paper
• Initiation and regulation of T-cell responses in tuberculosis

  2011cited by this paper
• Development of new vaccines and drugs for TB: limitations and potential strategic errors.

  2011cited by this paper
• Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis.

  2011cited by this paper
• Importance of Confirming Data on the In Vivo Efficacy of Novel Antibacterial Drug Regimens against Various Strains of Mycobacterium tuberculosis

  2011cited by this paper
• Comparative Studies Evaluating Mouse Models Used for Efficacy Testing of Experimental Drugs against Mycobacterium tuberculosis

  2010cited by this paper
• An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis

  2010cited by this paper
• Granuloma Encapsulation Is a Key Factor for Containing Tuberculosis Infection in Minipigs

  2010cited by this paper
• Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB.

  2010cited by this paper
• Evaluation of Standard Chemotherapy in the Guinea Pig Model of Tuberculosis

  2010cited by this paper
• Activities of TMC207, Rifampin, and Pyrazinamide against Mycobacterium tuberculosis Infection in Guinea Pigs

  2010cited by this paper
• The role of the granuloma in expansion and dissemination of early tuberculous infection.

  2009cited by this paper
• Evaluation of new vaccines for tuberculosis in the guinea pig model.

  2009cited by this paper
• Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis

  2009cited by this paper
• Higher susceptibility of type 1 diabetic rats to Mycobacterium tuberculosis infection.

  2008cited by this paper
• Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies.

  2008cited by this paper
• Testing of Experimental Compounds in a Relapse Model of Tuberculosis Using Granulocyte-Macrophage Colony-Stimulating Factor Gene-Disrupted Mice

  2008cited by this paper
• Metronidazole Lacks Antibacterial Activity in Guinea Pigs Infected with Mycobacterium tuberculosis

  2008cited by this paper
• Metronidazole lacks activity against Mycobacterium tuberculosis in an in vivo hypoxic granuloma model of latency.

  2008cited by this paper
• Extrapulmonary Dissemination of Mycobacterium bovis but Not Mycobacterium tuberculosis in a Bronchoscopic Rabbit Model of Cavitary Tuberculosis

  2008cited by this paper
• Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs.

  2007cited by this paper
• Correlates of immune protection from tuberculosis.

  2007cited by this paper
• Pulmonary Lymphatics Are Primary Sites of Mycobacterium tuberculosis Infection in Guinea Pigs Infected by Aerosol

  2006cited by this paper
• Zebrafish and Frog Models of Mycobacterium marinum Infection

  2006cited by this paper
• Mycobacterium marinum Infection of Adult Zebrafish Causes Caseating Granulomatous Tuberculosis and Is Moderated by Adaptive Immunity

  2006cited by this paper
• Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli.

  2005cited by this paper
• Rapid In Vivo Screening of Experimental Drugs for Tuberculosis Using Gamma Interferon Gene-Disrupted Mice

  2003cited by this paper
• Different Strains of Mycobacterium tuberculosis Cause Various Spectrums of Disease in the Rabbit Model of Tuberculosis

  2003cited by this paper
• Granuloma Formation in Mouse and Guinea Pig Models of Experimental Tuberculosis

  2003cited by this paper
• STUDIES ON THE MECHANISM OF IMMUNITY IN TUBERCULOSIS THE ROLE OF EXTP.ACELLULAR FACTORS AND LOCAL Im~UNITY IN THE FIXATION AND INHIBITION OF GROWTH OF TUBERCLE BACILLI

  2003cited by this paper
• Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos.

  2002cited by this paper
• CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis.

  2002cited by this paper
• Determinants of Vaccine-Induced Resistance in Animal Models of Pulmonary Tuberculosis

  2001cited by this paper
• A coordinated strategy for evaluating new vaccines for human and animal tuberculosis.

  2001cited by this paper
• CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis.

  2001cited by this paper
• Metronidazole Therapy in Mice Infected with Tuberculosis

  1999cited by this paper
• Pathogenesis of experimental tuberculosis in animal models.

  1996cited by this paper
• Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.

  1995cited by this paper
• An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

  1993cited by this paper
• Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis.

  1991cited by this paper
• The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis.

  1987cited by this paper
• Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients

  1983cited by this paper
• Transfer of Adoptive Immunity to Tuberculosis in Mice

  1975cited by this paper
• Importance of thymus-derived lymphocytes in cell-mediated immunity to infection.

  1973cited by this paper
• Immune Response to Mycobacterium tuberculosis in Rats

  1973cited by this paper
• Properties of lymphocytes which confer adoptive immunity to tuberculosis in rats.

  1973cited by this paper
• Pathogenesis of tuberculosis: local and systemic immunity and cellular hypersensitivity.

  1970cited by this paper
• Cellular hypersensitivity and cellular immunity in the pathogensis of tuberculosis: specificity, systemic and local nature, and associated macrophage enzymes.

  1968cited by this paper
• Letter to the editor.

  1967cited by this paper
• The relative natural resistance of rats and mice to experimental pulmonary tuberculosis

  1961cited by this paper
• Allergy in experimental rat tuberculosis

  1961cited by this paper
• Variations in natural resistance to tuberculosis

  1960cited by this paper
• The Principles of Humane Experimental Technique

  1960cited by this paper
• The response to the intracutaneous inoculation of BCG as an index of native resistance to tuberculosis.

  1952cited by this paper
• STUDIES ON THE MECHANISM OF IMMUNITY IN TUBERCULOSIS

  1942cited by this paper
• STUDIES ON THE MECHANISM OF IMMUNITY IN TUBERCULOSIS

  1939cited by this paper
• STUDIES ON THE MECHANISM OF IMMUNITY IN TUBERCULOSIS

  1939cited by this paper

• Large-scale testing of antimicrobial lethality at single-cell resolution predicts mycobacterial infection outcomes

  2026cites this paper
• pcDNA3.1-rpfB or pcDNA3.1-rpfD recombinant DNA prevents Mycobacterium tuberculosis infection in BALB/c mice

  2026cites this paper
• Co-administration of a synthetic saccharide conjugate vaccine with BCG provides synergistic protection against murine tuberculosis.

  2025cites this paper
• A DIVA-compatible Mycobacterium bovis triple mutant vaccine confers protection against bovine tuberculosis in mouse model.

  2025cites this paper
• The Central Importance of Vaccines to Mitigate the Threat of Antibiotic-Resistant Bacterial Pathogens

  2025cites this paper
• BCG and beyond: unlocking new frontiers in TB vaccine development

  2025cites this paper
• Experimental dissection of tuberculosis protective immunity: a human perspective

  2025cites this paper
• Dynamics of the In vitro Growing of Mycobacterium bovis from the Lungs of Vaccinated and Infected Mice.

  2025cites this paper
• A review of the efficacy of clinical tuberculosis vaccine candidates in mouse models

  2025cites this paper
• PET imaging of mycobacterial infection: transforming the pipeline for tuberculosis drug development

  2025cites this paper
• Systematic review of innate immune responses against Mycobacterium tuberculosis complex infection in animal models

  2025cites this paper
• Mycobacterium marinum as a model for understanding principles of mycobacterial pathogenesis

  2025cites this paper
• Advances in Antituberculosis Drug-induced Liver Injury: Molecular Mechanisms, Genetic Insights, and Emerging Animal-Free Prediction Models.

  2025cites this paper
• Systems genetics uncover new loci containing functional gene candidates in Mycobacterium tuberculosis-infected Diversity Outbred mice

  2024cites this paper
• Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals

  2024cites this paper
• Mathematical modeling suggests heterogeneous replication of Mycobacterium tuberculosis in rabbits

  2024cites this paper
• Antibiotic lethality dictates mycobacterial infection outcomes

  2024cites this paper
• Navigating ESKAPE Pathogens: Considerations and Caveats for Animal Infection Models Development

  2024cites this paper
• Animals in Respiratory Research

  2024cites this paper
• Integrative and comparative genomic analyses of mammalian macrophage responses to intracellular mycobacterial pathogens

  2023cites this paper
• Mathematical modeling suggests heterogeneous replication of Mycobacterium tuberculosis in rabbits

  2023cites this paper
• Systems genetics uncover new loci containing functional gene candidates in Mycobacterium tuberculosis-infected Diversity Outbred mice

  2023cites this paper
• Efficacy of RUTI® immunotherapy against active tuberculosis in a mouse model challenges the Koch phenomenon

  2023cites this paper
• Key advances in vaccine development for tuberculosis—success and challenges

  2023cites this paper
• Spatial mapping reveals granuloma diversity and histopathological superstructure in human tuberculosis

  2023cites this paper
• Accelerating research and development of new vaccines against tuberculosis: a global roadmap

  2022cites this paper
• Amyloid deposition in granuloma of tuberculosis patients: A single-center pilot study.

  2022cites this paper
• Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies

  2022cites this paper
• Innate Immune Responses of Galleria mellonella to Mycobacterium bovis BCG Challenge Identified Using Proteomic and Molecular Approaches

  2021cites this paper
• Lipid nanoparticles with improved biopharmaceutical attributes for tuberculosis treatment.

  2021cites this paper
• Progress and challenges in TB vaccine development [version 1; peer review: 2 approved]

  2021cites this paper
• Prolonged infection triggered by dormant Mycobacterium tuberculosis: Immune and inflammatory responses in lungs of genetically susceptible and resistant mice

  2020cites this paper
• HIV and the tuberculosis “set point”: how HIV impairs alveolar macrophage responses to tuberculosis and sets the stage for progressive disease

  2020cites this paper
• Integrative genomics of the mammalian alveolar macrophage response to intracellular mycobacteria

  2020cites this paper
• Drugs against Mycobacterium tuberculosis

  2020cites this paper
• A novel biosafety level 2 compliant tuberculosis infection model using a ΔleuDΔpanCD double auxotroph of Mycobacterium tuberculosis H37Rv and Galleria mellonella

  2020cites this paper
• relA is Achilles' heel for mycobacterial pathogens as demonstrated with deletion mutants in Mycobacterium avium subsp. paratuberculosis and mycobacterium bovis bacillus Calmette-Guérin (BCG).

  2020cites this paper
• Alveolar Macrophage Chromatin Is Modified to Orchestrate Host Response to Mycobacterium bovis Infection

  2020cites this paper
• Epidemiology and Control of Notifiable Animal Diseases

  2019cites this paper
• Determination of organ specific pharmacokinetic data for the anti-tuberculosis drugs in guinea pigs using microdialysis

  2019cites this paper
• LSHTM Research Online

  2019cites this paper
• A co-culture model of the bovine alveolus

  2019cites this paper
• LSHTM Research Online

  2019cites this paper
• An Auto-luminescent Fluorescent BCG Whole Blood Assay to Enable Evaluation of Paediatric Mycobacterial Responses Using Minimal Blood Volumes

  2019cites this paper
• Alveolar macrophage chromatin is uniquely modified to orchestrate host response to Mycobacterium bovis infection

  2019cites this paper
• Mastomys Species as Model Systems for Infectious Diseases

  2019cites this paper
• Research and development of new tuberculosis vaccines: a review

  2018cites this paper
• Pathogenesis of Mycobacterium bovis Infection: the Badger Model As a Paradigm for Understanding Tuberculosis in Animals

  2018cites this paper
• Research and development of new tuberculosis vaccines: a review.

  2018cites this paper
• Phase 2b placebo-controlled trial of M72/AS01E candidate vaccine to prevent active tuberculosis in adults

  2018cites this paper
• Trying to See the Forest through the Trees: Deciphering the Nature of Memory Immunity to Mycobacterium tuberculosis

  2018cites this paper
• Progress and challenges in TB vaccine development

  2018cites this paper
• Biology of clinical strains of Mycobacterium tuberculosis with varying levels of transmission

  2018cites this paper
• Integrating Lung Physiology, Immunology, and Tuberculosis.

  2017cites this paper
• GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis

  2017cites this paper
• Molecular Players in Tuberculosis Drug Development: Another Break in the Cell Wall.

  2017cites this paper